NOTIFICATION OF REMOVAL FROM LISTING AND/OR |
REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number 0-12183 |
BOVIE MEDICAL CORPORATION |
NYSE AMERICAN |
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) |
o | 17CFR 240.12d2-2(a)(1) |
o | 17CFR 240.12d2-2(a)(2) |
o | 17CFR 240.12d2-2(a)(3) |
o | 17CFR 240.12d2-2(a)(4) |
o | Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange |
ý | Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange |
December 31, 2018 | By: | /s/ Charles D. Goodwin II | President and Chief Executive Officer | |||
Date | Name: | Charles D. Goodwin II | Title |